Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center…
Jenny C. Yip, PsyD, ABPP, shares advice for HCPs who may be struggling with anxiety or depression as a result of months of practicing medicine and managing personal…
NEW YORK (Reuters Health) – The risk of developing post-pericardiotomy syndrome (PPS) in cardiac surgery patients can be halved by treatment with colchicine, an international team has shown.…
NEW YORK (Reuters Health) – Measuring both the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) when an inflammatory condition is suspected is not helpful and is possibly…
NEW YORK (Reuters Health) – A consensus statement compiled by an international panel proposes that the level of platelet reactivity during antiplatelet therapy is a better measure of…
NEW YORK (Reuters Health) – In high vascular risk patients, addition of clopidogrel to treatment with acetylsalicylic acid does not help minimize untoward events, researchers report in the…
NEW YORK (Reuters Health) – The mineral composition of kidney stones reported by commercial laboratories is often inaccurate, investigators at Indiana University, Indianapolis report in the Journal of…
NEW YORK (Reuters Health) – As is seen in certain other gastrointestinal illnesses, the prevalence of low-trauma fractures is higher among patients with chronic pancreatitis than in the…
NEW YORK (Reuters Health) – Elderly subjects who need to void two or more times during the night have an increased risk of sustaining a fracture and of…
NEW YORK (Reuters Health) – Despite numerous advances in treatment, evidence-based outpatient therapy for congestive heart failure (CHF) has not improved since 2002, researchers report in the August…
NEW YORK (Reuters Health) – The 10-year outcomes data from the MASS II trial comparing coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI) and medical treatment for…
NEW YORK (Reuters Health) – Cardiac resynchronization therapy for a year improves cardiac size and performance in patients with mildly symptomatic heart failure, resulting in improved outcomes, according…
